Urinary Prostaglandin E2 Metabolite and Pancreatic Cancer Risk: Case-Control Study in Urban Shanghai
Zhao J, Wang J, Du J, Xu H, Zhang W, Ni QX, Yu H, Risch HA, Gao YT, Gao Y. Urinary Prostaglandin E2 Metabolite and Pancreatic Cancer Risk: Case-Control Study in Urban Shanghai. PLOS ONE 2015, 10: e0118004. PMID: 25679523, PMCID: PMC4332509, DOI: 10.1371/journal.pone.0118004.Peer-Reviewed Original ResearchConceptsCase-control studyPancreatic cancer riskPancreatic cancerOdds ratioCancer riskRecent population-based case-control studiesPopulation-based case-control studyUrinary PGE-M levelsUrinary prostaglandin E2 metabolitePGE-M levelsProstaglandin E2 metaboliteProstaglandin E2 metabolite levelsHigh meat intakePancreatic ductal adenocarcinoma casesUnconditional logistic regressionCOX-2 pathwayConfidence intervalsPancreatic ductal adenocarcinomaUrinary PGEDiabetes historyThird tertileE2 metaboliteDuctal adenocarcinomaMeat intakeAdenocarcinoma cases